Sinopharm Group Co. Ltd. (FRA:X2S)
2.256
+0.033 (1.48%)
At close: Jan 9, 2026
Sinopharm Group Market Cap
Sinopharm Group has a market cap or net worth of €7.12 billion as of January 9, 2026. Its market cap has decreased by -15.90% in one year.
Market Cap
7.12B
Enterprise Value
18.50B
Revenue
68.67B
Ranking
n/a
PE Ratio
8.40
Stock Price
€2.26
Market Cap Chart
Since September 23, 2009, Sinopharm Group's market cap has increased from 3.53B to 7.12B, an increase of 101.59%. That is a compound annual growth rate of 4.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 7.12B | 7.22% |
| Dec 31, 2025 | 6.64B | -19.69% |
| Dec 31, 2024 | 8.27B | 11.84% |
| Dec 29, 2023 | 7.39B | -0.53% |
| Dec 30, 2022 | 7.43B | 24.49% |
| Dec 31, 2021 | 5.97B | -3.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 247.30B |
| Siemens Aktiengesellschaft | 197.59B |
| Allianz SE | 145.37B |
| Deutsche Telekom AG | 134.99B |
| Siemens Energy AG | 107.65B |
| Rheinmetall AG | 87.17B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 67.47B |
| Deutsche Bank Aktiengesellschaft | 63.02B |